Quantcast

Latest Securities Stories

2014-10-31 16:24:20

IRVINE, Calif., Oct. 31, 2014 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced the closing of its follow-on public offering of 4,000,000 shares of common stock, with each share of common stock being sold together with 1.25 warrants to purchase one share of common stock. The securities were sold at a price to the public of...

2014-10-31 16:22:17

ANNAPOLIS, Md., Oct. 31, 2014 /PRNewswire/ -- Hannon Armstrong Sustainable Infrastructure Capital, Inc. (the "Company") (NYSE: HASI) announced today the closing of its underwritten public offering of 4,600,000 shares of common stock at a price of $13.60 per share. This amount includes the exercise in full by the underwriters of their option to purchase up to an additional 600,000 shares of common stock. http://photos.prnewswire.com/prnvar/20130808/PH61447LOGO BofA Merrill Lynch,...

2014-10-30 12:24:12

LONDON, October 30, 2014 /PRNewswire/ -- The following documents (the "Documents") are available for viewing: Prospectus Supplement dated 30 October 2014 Royal Dutch Shell plc unaudited consolidated interim financial statements for the nine month period ended 30 September 2014 The Documents must be read in conjunction with the Information Memorandum dated 13 August 2014, as supplemented by the first supplement dated 28 August 2014 and by the second...

2014-10-30 08:43:42

MILPITAS, Calif., Oct. 30, 2014 /PRNewswire/ -- KLA-Tencor Corporation (NASDAQ: KLAC) today announced that it intends to offer, subject to market and other conditions, senior notes under an automatic shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). Logo - http://photos.prnewswire.com/prnh/20140123/SF50413LOGO J.P. Morgan Securities LLC is acting as the sole book-running manager of the offering. KLA-Tencor has filed an effective...

2014-10-30 08:28:49

THE HAGUE, The Netherlands, October 30, 2014 /PRNewswire/ -- The Board of Royal Dutch Shell plc (NYSE:RDS.A)(NYSE: RDS.B) today announced the intended timetable for the 2015 quarterly interim dividends. 2015 Interim Dividend Timetable 4th Quarter 2014 1st Quarter 2015 2nd Quarter 2015 3rd Quarter 2015 Announcement date January 29, 2015 April 30, 2015 July...

2014-10-30 08:25:26

LONDON, October 30, 2014 /PRNewswire/ -- The following document (the "Document") is available for viewing: Prospectus Supplement dated 29 October 2014 The Document must be read in conjunction with the Information Memorandum dated 13 August 2014, as supplemented by the first supplement dated 28 August 2014, relating to the Programme. The Information Memorandum constitutes a base prospectus for the purposes of Article 5.4 of Directive 2003/71/EC as amended. Full...

2014-10-29 08:34:48

WASHINGTON, Oct. 29, 2014 /PRNewswire/ - Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced the sale of 5,000,000 shares of its common stock in an underwritten public offering at a price to the public of $11.60 per share. The net offering proceeds to Vanda from the sale of the shares are expected to be approximately $54.0 million, after deducting underwriting discounts and commissions and other estimated offering expenses, but excluding any exercise of the...

2014-10-28 20:24:05

LA JOLLA, Calif., Oct. 28, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today announced the pricing of an underwritten public offering of 5,294,118 shares of its common stock at a price to the public of $17.00 per share. 4,411,765 shares are being sold by Regulus and 882,353 shares are being sold by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. (NASDAQ: ISIS). Regulus...

2014-10-28 20:23:36

IRVINE, Calif., Oct. 28, 2014 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock and warrants to purchase up to an aggregate of 5,000,000 shares of its common stock, with each share of common stock being sold together with 1.25 warrants...

2014-10-28 16:28:01

WASHINGTON, Oct. 28, 2014 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Vanda also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related